BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Fanconi Anemia Complementation Group L Protein

Below is an extended Fanconi Anemia Complementation Group L Protein research listing. Click here to return to the Fanconi Anemia Complementation Group L Protein main in depth entry.

Recent Publications on Fanconi Anemia Complementation Group L Protein:

[Functions of FANCL in primordial germ cell formation and Fanconi anemia] 19th August, 2008
Beijing Institute of Biotechnology, Beijing 100071, China.
UBE2T, the Fanconi anemia core complex, and FANCD2 are recruited independently to chromatin: a basis for the regulation of FANCD2 monoubiquitination.
The Fanconi anemia (FA) nuclear core complex and the E2...
Direct Link
19th December, 2007
Laboratory of Molecular Biology, Medical Research Council, Cambridge,
FAAP100 is essential for activation of the Fanconi anemia-associated DNA damage response pathway.
The Fanconi anemia (FA) core complex plays a central role in the DNA...
Direct Link
5th October, 2007
Laboratory of Genetics, National Institute on Aging, National Institutes
Altered expression of FANCL confers mitomycin C sensitivity in Calu-6 lung cancer cells. 26th May, 2007
Department of Laboratory Medicine and Pathology, Mayo Clinic College of
A requirement of FancL and FancD2 monoubiquitination in DNA repair.
The rare hereditary disorder Fanconi anemia (FA) can be caused by...
Direct Link
4th May, 2007
Department of Immunology and Molecular Genetics, Kawasaki Medical School,
Drosophila homologs of FANCD2 and FANCL function in DNA repair.
Fanconi anemia (FA) is a genetically heterogeneous disease characterized...
Direct Link
6th January, 2007
Department of Genetics, Yale University School of Medicine, 333 Cedar St.,
Evidence for subcomplexes in the Fanconi anemia pathway.
Fanconi anemia (FA) is a genomic instability disorder, clinically...
Direct Link
17th October, 2006
Department of Clinical Genetics and Human Genetics, Vrije Universiteit
UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation.
The Fanconi anemia pathway is required for the efficient repair of damaged...
Direct Link
20th September, 2006
Department of Biochemistry and Molecular Genetics, University of Virginia
The WD40 repeats of FANCL are required for Fanconi anemia core complex assembly.
Fanconi anemia (FA) is an autosomal recessive disorder characterized by...
Direct Link
14th June, 2006
Biological and Biomedical Sciences Program, Dana-Farber Cancer Institute,
Inducibility of nuclear Rad51 foci after DNA damage distinguishes all Fanconi anemia complementation groups from D1/BRCA2.
Fanconi anemia (FA) is a cancer susceptibility disorder characterized by...
Direct Link
29th March, 2006
Department of Toxicogenetics, Leiden University Medical Center,
Germ-cell specific protein gametogenetin protein 2 (GGN2), expression in the testis, and association with intracellular membrane.
Gametogenetin (Ggn) is a germ cell-specific gene with multiple splicing...
Direct Link
3rd November, 2005
Beijing Institute of Biotechnology, Beijing, China.
A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M.
Fanconi anemia is a genetic disease characterized by genomic instability...
Direct Link
30th September, 2005
Division of Experimental Hematology, Cincinnati Children's Hospital
FANCL replaces BRCA1 as the likely ubiquitin ligase responsible for FANCD2 monoubiquitination. 22nd May, 2004
Laboratory of Genetics, National Institute on Aging, National Institutes
A novel ubiquitin ligase is deficient in Fanconi anemia.
Fanconi anemia is a recessively inherited disease characterized by...
Direct Link
9th December, 2003
Laboratory of Genetics, National Institute on Aging, National Institutes
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional